/ Orchid Pharma Gets US FDA Approval For Aripiprazole Tablet ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Wednesday, 24 May 2017

Orchid Pharma Limited, in its BSE filing on Wednesday, announced that it has received Abbreviated New Drug Application (ANDA) approval from US FDA for Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg.

Aripiprazole Tablets are atypical antipsychotic indicated for the treatment symptoms of psychotic conditions such as schizophrenia and bipolar disorder (manic depression), said Orchid Pharma.

 Orchid Pharma Limited was trading at Rs 30.25, up by Rs 0.60 or 2.02%, on Wednesday, on the BSE. The stock had hit an intraday high of Rs 31.85.

Orchid Chemicals & Pharmaceuticals Ltd (Orchid) is a globally recognised, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well as in drug discovery, which was incorporated on 1st July 1992 as a 100% Export Oriented Unit (EOU). 

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717